Cas:324028-87-7 Methyl 5,6-dimethoxypicolinate manufacturer & supplier

Chemical Name:Methyl 5,6-dimethoxypicolinate

CAS.NO:324028-87-7

Synonyms:A-6434;Methyl 5,6-dimethoxypicolinate

Molecular Formula:C₉H₁₁NO₄

Molecular Weight:197.18800

HS Code:2933399090

Physical and Chemical Properties:

Melting point:N/A

Boiling point:N/A

Density:N/A

Index of Refraction:

PSA:57.65000

Exact Mass:197.06900

LogP:0.88540

Material Safety Information (Applicable for Hazard Chemicals)

RIDADR:NONH for all modes of transpor

Packing Group:

Contact us for information like A-6434 chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,Methyl 5,6-dimethoxypicolinate physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,Methyl 5,6-dimethoxypicolinate Use and application,A-6434 technical grade,usp/ep/jp grade.

Related News: The outlook for a cure is clouded with theoretical uncertainties and high-profile failures. Pharmaceutical giants including Johnson & Johnson, Merck and Pfizer have ditched their projects on unsatisfactory data. Methyl 5,6-dimethoxypicolinate manufacturer In addition, the FDA approval ignored the recommendation of its outside advisors, who said Biogen did not provide enough evidence of clinical benefit. Three of the advisory panel’s members have resigned in protest since the FDA decision was announced on Monday. Methyl 5,6-dimethoxypicolinate supplier By recapitulating the tumor microenvironment and using a live-cell, function-first approach, Resonant��s platform generates therapeutic candidates that would not be discovered by other methods with unprecedented speed. Methyl 5,6-dimethoxypicolinate vendor In order to seize the highest point of profits, international industry giants have adjusted their development strategies, concentrated their energies on the two ends of the smile curve-research and development and end products, and shifted production links such as intermediates and APIs outward. A division of labor model has been formed. Methyl 5,6-dimethoxypicolinate factory The outlook for a cure is clouded with theoretical uncertainties and high-profile failures. Pharmaceutical giants including Johnson & Johnson, Merck and Pfizer have ditched their projects on unsatisfactory data.